Data / Form D filings / Abata Therapeutics, Inc.
Abata Therapeutics, Inc.: Form D filings
Abata Therapeutics, Inc., a biotechnology company in Watertown, MA, filed 3 Form D notices with the SEC between 2021 and 2023. The latest, on December 27, 2023, reports $15.3 million sold of an offering with no set size to 8 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 100 FORGE ROAD, SUITE 200, Watertown, MA, 02472
- Phone
- (857) 230-0070
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1867989
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 27, 2023 | New notice | Indefinite | $15,332,894 | 8 | Dec 14, 2023 | sec.gov | |
| Jun 16, 2022 | Amendment | $95,000,000 | $45,000,000 | $50,000,000 | 7 | Jun 4, 2021 | sec.gov |
| Jun 21, 2021 | New notice | $95,000,000 | $45,000,000 | $50,000,000 | 7 | Jun 4, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| SAMANTHA SINGER | Executive Officer, Director | |
| LEONARD DRAGONE | Executive Officer | |
| VALERIE ODEGARD | Director | |
| STEPHEN SOFEN | Executive Officer | |
| SANDY LAZZARI | Executive Officer | |
| SHELLEY CHU | Director | |
| NAGESH MAHANTHAPPA | Director | |
| JOHN TRZUPEK | Executive Officer | |
| ABBIE CELNIKER | Director | |
| MITCH FINER | Director | |
| DAVID KAUFMAN | Director | |
| LORENCE KIM | Director | |
| ELLEN CAHIR-MCFARLAND | Executive Officer |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Dec 25, 2023 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Abata Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.